Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity

Vol. 207, No. 10, September 27, 2010. Pages 2187–2194.

The authors regret their failure to cite support from the National Institutes of Health (grant AI056299). The authors also regret that G. Freeman was not acknowledged for provision of anti–PD-L1 antibody.

The html and pdf versions of this article have been corrected.